These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 12122509

  • 21. Assessing the risk of infection and rejection in Hispanic renal transplant recipients by means of an adenosine triphosphate release assay.
    Cadillo-Chávez R, de Echegaray S, Santiago-Delpín EA, Rodríguez-Trinidad AT, Camacho-Carrazo B, Alfaro T, Saavedra-Pozo M, Carrasquillo L, González-Caraballo ZA, Morales-Otero LA.
    Transplant Proc; 2006 Apr; 38(3):918-20. PubMed ID: 16647510
    [Abstract] [Full Text] [Related]

  • 22. Soluble tumor necrosis factor receptors are elevated in relation to severity of congestive heart failure.
    Nozaki N, Yamaguchi S, Shirakabe M, Nakamura H, Tomoike H.
    Jpn Circ J; 1997 Aug; 61(8):657-64. PubMed ID: 9276770
    [Abstract] [Full Text] [Related]

  • 23. [Tumor necrosis factor receptors sTNF-RI and sTNF-RII in advanced chronic heart failure].
    Nowak J, Rozentryt P, Szewczyk M, Gierlotka M, Duszańska A, Szyguła B, Wojnicz R, Hawranek M, Poloński L, Zembala M.
    Pol Arch Med Wewn; 2002 Mar; 107(3):223-9. PubMed ID: 12107980
    [Abstract] [Full Text] [Related]

  • 24. Value of soluble CD30 in liver transplantation.
    Fábrega E, Unzueta MG, Cobo M, Casafont F, Amado JA, Romero FP.
    Transplant Proc; 2007 Sep; 39(7):2295-6. PubMed ID: 17889168
    [Abstract] [Full Text] [Related]

  • 25. Elevated serum levels of the type I and type II receptors for tumor necrosis factor-alpha as predictive factors for ARF in patients with septic shock.
    Iglesias J, Marik PE, Levine JS, Norasept II Study Investigators.
    Am J Kidney Dis; 2003 Jan; 41(1):62-75. PubMed ID: 12500222
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Soluble CD30 as a prognostic factor for outcome following renal transplantation.
    Platt RE, Wu KS, Poole K, Newstead CG, Clark B.
    J Clin Pathol; 2009 Jul; 62(7):662-3. PubMed ID: 19561239
    [Abstract] [Full Text] [Related]

  • 28. Soluble CD30 for the prediction and detection of kidney transplant rejection.
    Arjona A.
    Drug News Perspect; 2009 Sep; 22(7):409-13. PubMed ID: 19890498
    [Abstract] [Full Text] [Related]

  • 29. Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection.
    Slavcev A, Lácha J, Honsová E, Sajdlová H, Lodererová A, Vitko S, Skibová J, Striz I.
    Transpl Immunol; 2005 Jun; 14(2):117-21. PubMed ID: 15935302
    [Abstract] [Full Text] [Related]

  • 30. Immunological monitoring after organ transplantation: potential role of soluble CD30 blood level measurement.
    Truong DQ, Darwish AA, Gras J, Wieërs G, Cornet A, Robert A, Mourad M, Malaise J, de Ville de Goyet J, Reding R, Latinne D.
    Transpl Immunol; 2007 Jun; 17(4):283-7. PubMed ID: 17493532
    [Abstract] [Full Text] [Related]

  • 31. Increased serum levels of soluble tumor necrosis factor receptors (sTNF-Rs) in children and adolescents with vertically and horizontally transmitted HIV infection.
    Weiss M, Martignoni M, Petropoulou T, Sölder B, Belohradsky BH.
    Infection; 1996 Jun; 24(4):301-8. PubMed ID: 8875282
    [Abstract] [Full Text] [Related]

  • 32. Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer.
    Gregorc V, Spreafico A, Floriani I, Colombo B, Ludovini V, Pistola L, Bellezza G, Viganò MG, Villa E, Corti A.
    Cancer; 2007 Aug 15; 110(4):845-53. PubMed ID: 17599769
    [Abstract] [Full Text] [Related]

  • 33. Plasma concentrations of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in patients with bulimia nervosa.
    Nakai Y, Hamagaki S, Takagi R, Taniguchi A, Kurimoto F.
    Clin Endocrinol (Oxf); 2000 Sep 15; 53(3):383-8. PubMed ID: 10971457
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of pre- and posttransplantation serum interferon-gamma and soluble CD30 for predicting liver allograft rejection.
    Kim KH, Oh EJ, Jung ES, Park YJ, Choi JY, Kim DG, Lee KY, Kang CS.
    Transplant Proc; 2006 Jun 15; 38(5):1429-31. PubMed ID: 16797323
    [Abstract] [Full Text] [Related]

  • 35. Correlation of serum soluble TNF-alpha receptors I and II levels with disease activity in patients with ulcerative colitis.
    Hanai H, Watanabe F, Yamada M, Sato Y, Takeuchi K, Iida T, Tozawa K, Tanaka T, Maruyama Y, Matsushita I, Iwaoka Y, Saniabadi A.
    Am J Gastroenterol; 2004 Aug 15; 99(8):1532-8. PubMed ID: 15307873
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. High serum soluble CD30 does not predict acute rejection in liver transplant patients.
    Matinlauri I, Höckerstedt K, Isoniemi H.
    Transplant Proc; 2006 Dec 15; 38(10):3601-4. PubMed ID: 17175343
    [Abstract] [Full Text] [Related]

  • 38. Soluble tumor necrosis factor receptor (sTNF RII) in sera of children and traffic-derived particulate air pollution.
    Cox FA, Stiller-Winkler R, Hadnagy W, Ranft U, Idel H.
    Zentralbl Hyg Umweltmed; 1999 Dec 15; 202(6):489-500. PubMed ID: 10631790
    [Abstract] [Full Text] [Related]

  • 39. Association between serum soluble CD30 and serum creatinine before and after renal transplantation.
    López-Hoyos M, San Segundo D, Benito MJ, Fernández-Fresnedo G, Ruiz JC, Rodrigo E, Gómez-Alamillo C, Benito A, Arias M.
    Transplant Proc; 2008 Nov 15; 40(9):2903-5. PubMed ID: 19010142
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.